Nexgen Pharma Acquired by LGM Pharma
Represented Nexgen Pharma, Inc., a recognized leader specializing in the development and manufacture of solid dose, powder, semi-solid, and liquid Rx and OTC drugs in its acquisition by LGM Pharma. The combined firm, which will continue to be known as LGM Pharma, has all the capabilities needed to help pharmaceutical and biotechnology customers accelerate and optimize the new product pathway, from early R&D and clinical development through manufacturing, regulatory submission, commercialization and distribution.
We are proud of the pharmaceutical CDMO business our family and talented employees built over many years and are delighted the business has been acquired by LGM Pharma, which is an ideal partner to carry on our tradition of quality and service while expanding the range of capabilities and services for our respective customers,” said Kyle Brown, CEO of Nexgen Pharma."
